Zofran Lawsuits - Linked to Birth Defects A growing body of reports raise concerns regarding the serious side effects of Zofran (ondansetron) when used to treat morning sickness associated with pregnancy. According to reports, women who use Zofran while pregnant may be at a 30% increased risk of having a child with birth defects. A 2011 study found that drugs such as Zofran can double the chance of a baby being born with cleft palate.
Other reported birth defects include:
- Cleft Lip
- Heart Defects
- Kidney Malformations
- Musculoskeletal abnormalities
- Fetal Death
According to a recent study, approximately 10-15% of pregnant women use medications to treat morning sickness. Although Zofran is widely used by women during pregnancy, the FDA has never approved the drug to treat morning sickness. Zofran has only been approved by the FDA to treat anti-nausea associated with surgery and chemotherapy.
In 2012, GSK agreed to pay $3-billion to settle claims with the U.S. Department of Justice for a variety of civil and criminal allegations. As part of the settlement, GSK agreed to resolve its civil liability for promoting several drugs, including Zofran, for off-label use. Plaintiffs across the country have begun filing lawsuits against GlaxoSmithKline alleging Zofran caused birth defects. Considering that Zofran has been on the market since the early 1990’s, the potential for widespread litigation is imminent.
Cases are stronger when an attorney is involved early. Call and speak with one now:
Have you or a loved one suffered from birth defects that may have been caused by Zofran? If so, call one of our experienced pharmaceutical drug attorneys at 1-888-728-9866 for a free consultation. Or, simply fill in the requested information on the right side of the screen and one of our attorneys will contact you to gather more information.
Meshbesher & Spence has a proud history of preserving and defending the welfare of injured people for more than 60 years.